XTX Topco’s Oramed Pharmaceuticals ORMP Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | – | Sell |
-24,716
| Closed | -$60.3K | – | 2747 |
|
2024
Q3 | $60.3K | Buy |
24,716
+9,242
| +60% | +$22.6K | ﹤0.01% | 1662 |
|
2024
Q2 | $39.8K | Buy |
+15,474
| New | +$39.8K | ﹤0.01% | 1533 |
|
2024
Q1 | – | Sell |
-17,325
| Closed | -$40K | – | 2184 |
|
2023
Q4 | $40K | Buy |
+17,325
| New | +$40K | 0.01% | 1274 |
|
2023
Q2 | – | Sell |
-151,620
| Closed | -$331K | – | 1718 |
|
2023
Q1 | $331K | Buy |
151,620
+94,537
| +166% | +$206K | 0.07% | 579 |
|
2022
Q4 | $687K | Buy |
+57,083
| New | +$687K | 0.15% | 179 |
|
2022
Q3 | – | Sell |
-18,174
| Closed | -$83K | – | 1309 |
|
2022
Q2 | $83K | Buy |
+18,174
| New | +$83K | 0.03% | 687 |
|
2022
Q1 | – | Sell |
-10,556
| Closed | -$151K | – | 887 |
|
2021
Q4 | $151K | Buy |
+10,556
| New | +$151K | 0.09% | 409 |
|